Diamond Hill Capital Management Inc. Boosts Stake in The Cooper Companies, Inc. $COO

Diamond Hill Capital Management Inc. lifted its position in The Cooper Companies, Inc. (NASDAQ:COO) by 479.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,287,837 shares of the medical device company’s stock after acquiring an additional 2,720,594 shares during the period. Cooper Companies accounts for about 1.4% of Diamond Hill Capital Management Inc.’s investment portfolio, making the stock its 26th largest holding. Diamond Hill Capital Management Inc.’s holdings in Cooper Companies were worth $269,471,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Bell Investment Advisors Inc boosted its position in shares of Cooper Companies by 106.3% during the third quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock valued at $29,000 after purchasing an additional 219 shares in the last quarter. CYBER HORNET ETFs LLC bought a new position in Cooper Companies in the second quarter worth $36,000. True Wealth Design LLC lifted its position in Cooper Companies by 484.8% during the fourth quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock valued at $38,000 after buying an additional 383 shares during the period. Cromwell Holdings LLC boosted its holdings in shares of Cooper Companies by 128.8% during the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock valued at $40,000 after buying an additional 273 shares in the last quarter. Finally, Board of the Pension Protection Fund bought a new stake in shares of Cooper Companies during the 4th quarter valued at $41,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

COO has been the subject of several research reports. Needham & Company LLC increased their price target on shares of Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a research note on Friday, March 6th. Citigroup dropped their price objective on shares of Cooper Companies from $88.00 to $87.00 and set a “neutral” rating on the stock in a research note on Friday, March 6th. Rothschild & Co Redburn cut shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price objective on the stock. in a report on Wednesday, March 4th. Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. Finally, William Blair raised Cooper Companies to a “strong-buy” rating in a research report on Friday, January 30th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $90.79.

Cooper Companies Stock Performance

Shares of Cooper Companies stock opened at $62.85 on Friday. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The firm’s 50-day moving average is $67.14 and its 200 day moving average is $75.23. The stock has a market cap of $12.26 billion, a price-to-earnings ratio of 31.11, a PEG ratio of 1.59 and a beta of 0.89. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. Cooper Companies’s revenue was up 6.2% compared to the same quarter last year. During the same period last year, the business earned $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Sell-side analysts anticipate that The Cooper Companies, Inc. will post 4.62 EPS for the current fiscal year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.